{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:09:02Z","timestamp":1778594942926,"version":"3.51.4"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,20]]},"DOI":"10.1093\/ejendo\/lvad080","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T18:44:07Z","timestamp":1689273847000},"page":"R1-R3","source":"Crossref","is-referenced-by-count":1,"title":["Pituitary tumor prognostication: WHO is really the best?"],"prefix":"10.1093","volume":"189","author":[{"given":"Nicolas","family":"Sahakian","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Aix Marseille University, MMG, INSERM U1251, MARMARA Institute, APHM, H\u00f4pital de la Conception, CRMR HYPO , Marseille 13005 , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Dufour","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Aix Marseille University, MMG, INSERM U1251, MARMARA Institute, APHM, H\u00f4pital de la Timone, CRMR HYPO , Marseille 13005 , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8482-6691","authenticated-orcid":false,"given":"Thierry","family":"Brue","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Aix Marseille University, MMG, INSERM U1251, MARMARA Institute, APHM, H\u00f4pital de la Conception, CRMR HYPO , Marseille 13005 , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8440-0030","authenticated-orcid":false,"given":"Thomas","family":"Cuny","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Aix Marseille University, MMG, INSERM U1251, MARMARA Institute, APHM, H\u00f4pital de la Conception, CRMR HYPO , Marseille 13005 , France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"issue":"1","key":"2023072022471938400_lvad080-B1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2023072022471938400_lvad080-B2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"issue":"6","key":"2023072022471938400_lvad080-B3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocr Rev"},{"issue":"1","key":"2023072022471938400_lvad080-B4","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomass","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2023072022471938400_lvad080-B5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jocn.2016.09.014","article-title":"Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas","volume":"34","author":"Zaidi","year":"2016","journal-title":"J Clin Neurosci"},{"issue":"10","key":"2023072022471938400_lvad080-B6","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1179\/016164110X12670144737855","article-title":"Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review","volume":"32","author":"De Aguiar","year":"2010","journal-title":"Neurol Res"},{"issue":"1","key":"2023072022471938400_lvad080-B7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12022-018-9563-2","article-title":"The prognostic roles of the Ki-67 proliferation index, P53 expression, mitotic index, and radiological tumor invasion in pituitary adenomas","volume":"30","author":"Hasanov","year":"2019","journal-title":"Endocr Pathol"},{"key":"2023072022471938400_lvad080-B8","author":"Tumor Grade\u2014NCI [Internet]"},{"key":"2023072022471938400_lvad080-B9","author":"Cancer grading | Cancer Research UK [Internet]"},{"issue":"3","key":"2023072022471938400_lvad080-B10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1530\/EJE-17-0965","article-title":"Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients","volume":"178","author":"Lelotte","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2023072022471938400_lvad080-B11","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1210\/jc.2017-00773","article-title":"Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification","volume":"102","author":"Raverot","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023072022471938400_lvad080-B12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/EJE-18-0749","article-title":"Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre","volume":"180","author":"Asioli","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"2023072022471938400_lvad080-B13","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-023-01319-2","article-title":"Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese cohort of 129 patients from a tertiary pituitary center","author":"Peixe","year":"2023","journal-title":"Pituitary"},{"issue":"6","key":"2023072022471938400_lvad080-B14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1530\/EJE-22-0812","article-title":"Real-life clinical impact of a five-tiered classification of pituitary tumors","volume":"187","author":"Sahakian","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023072022471938400_lvad080-B15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cen.14197","article-title":"A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours (PitNET)s","volume":"93","author":"Guaraldi","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023072022471938400_lvad080-B16","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1093\/ejendo\/lvad042","article-title":"Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?\u2014that is the question","volume":"188","author":"Trouillas","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2023072022471938400_lvad080-B17","doi-asserted-by":"crossref","first-page":"e230021","DOI":"10.1530\/ERC-23-0021","article-title":"The World Health Organization classifications of pituitary neuroendocrine tumours: a clinico-pathological appraisal","volume":"30","author":"Villa","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2023072022471938400_lvad080-B18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11102-022-01235-x","article-title":"The NETting of pituitary adenoma: a gland illusion","volume":"25","author":"Ho","year":"2022","journal-title":"Pituitary"},{"issue":"12","key":"2023072022471938400_lvad080-B19","doi-asserted-by":"crossref","first-page":"e220385","DOI":"10.1530\/EC-22-0385","article-title":"Patient journey experiences may contribute to improve healthcare for patients with rare endocrine diseases","volume":"11","author":"Webb","year":"2022","journal-title":"Endocr Connect"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvad080\/50879834\/lvad080.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/1\/R1\/50919671\/lvad080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/1\/R1\/50919671\/lvad080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T22:47:40Z","timestamp":1689893260000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/189\/1\/R1\/7223898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvad080","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,7]]}}}